157 related articles for article (PubMed ID: 37389815)
1. Free interleukin-18 is elevated in CD22 CAR T-cell-associated hemophagocytic lymphohistiocytosis-like toxicities.
Rocco JM; Inglefield J; Yates B; Lichtenstein DA; Wang Y; Goffin L; Filipovic D; Schiffrin EJ; Shah NN
Blood Adv; 2023 Oct; 7(20):6134-6139. PubMed ID: 37389815
[No Abstract] [Full Text] [Related]
2. Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Lichtenstein DA; Schischlik F; Shao L; Steinberg SM; Yates B; Wang HW; Wang Y; Inglefield J; Dulau-Florea A; Ceppi F; Hermida LC; Stringaris K; Dunham K; Homan P; Jailwala P; Mirazee J; Robinson W; Chisholm KM; Yuan C; Stetler-Stevenson M; Ombrello AK; Jin J; Fry TJ; Taylor N; Highfill SL; Jin P; Gardner RA; Shalabi H; Ruppin E; Stroncek DF; Shah NN
Blood; 2021 Dec; 138(24):2469-2484. PubMed ID: 34525183
[TBL] [Abstract][Full Text] [Related]
3. CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.
Shah NN; Highfill SL; Shalabi H; Yates B; Jin J; Wolters PL; Ombrello A; Steinberg SM; Martin S; Delbrook C; Hoffman L; Little L; Ponduri A; Qin H; Qureshi H; Dulau-Florea A; Salem D; Wang HW; Yuan C; Stetler-Stevenson M; Panch S; Tran M; Mackall CL; Stroncek DF; Fry TJ
J Clin Oncol; 2020 Jun; 38(17):1938-1950. PubMed ID: 32286905
[TBL] [Abstract][Full Text] [Related]
4. Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature.
Major A; Collins J; Craney C; Heitman AK; Bauer E; Zerante E; Stock W; Bishop MR; Jasielec J
Leuk Lymphoma; 2021 Jul; 62(7):1765-1769. PubMed ID: 33559517
[No Abstract] [Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.
Hines MR; Keenan C; Maron Alfaro G; Cheng C; Zhou Y; Sharma A; Hurley C; Nichols KE; Gottschalk S; Triplett BM; Talleur AC
Br J Haematol; 2021 Aug; 194(4):701-707. PubMed ID: 34263927
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic Lymphohistiocytosis Secondary to T Cell/Histiocyte-rich Large B Cell Lymphoma in an Adolescent Male.
Metts JL; Park SI; Briones MA; Keller FG
Pediatr Dev Pathol; 2018; 21(1):95-99. PubMed ID: 29187030
[TBL] [Abstract][Full Text] [Related]
7. A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy.
Zu C; Wu S; Zhang M; Wei G; Xu H; Cui J; Chang AH; Huang H; Hu Y
Cytotherapy; 2023 Nov; 25(11):1167-1175. PubMed ID: 37480884
[TBL] [Abstract][Full Text] [Related]
8. Hemophagocytic lymphohistiocytosis and visceral leishmaniasis in children: case report and systematic review of literature.
Scalzone M; Ruggiero A; Mastrangelo S; Trombatore G; Ridola V; Maurizi P; Riccardi R
J Infect Dev Ctries; 2016 Jan; 10(1):103-8. PubMed ID: 26829545
[TBL] [Abstract][Full Text] [Related]
9. Secondary hemophagocytic lymphohistiocytosis induced by cholecystitis: A case report and a review of the literature.
Jin CQ; Dong HX; Zhou JW; Jia YX
Clin Chim Acta; 2016 Sep; 460():236-9. PubMed ID: 27423920
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometry in the diagnosis of hemophagocytic lymphohistiocytosis in a case with fatal outcome].
Pállinger E; Erdélyi D; Kovács G; Kriván G; Korponay Z; Fekete G; Szabó A; Falus A; Dérfalvi B
Orv Hetil; 2014 Mar; 155(10):389-95. PubMed ID: 24583560
[TBL] [Abstract][Full Text] [Related]
11. Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia.
Masih KE; Ligon JA; Yates B; Shalabi H; Little L; Islam Z; Ombrello AK; Inglefield J; Nussenblatt V; Manion M; Khan J; Shah NN
Pediatr Blood Cancer; 2021 Oct; 68(10):e29247. PubMed ID: 34309174
[TBL] [Abstract][Full Text] [Related]
12. Familial Hemophagocytic Lymphohistiocytosis.
Degar B
Hematol Oncol Clin North Am; 2015 Oct; 29(5):903-13. PubMed ID: 26461150
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic Lymphohistiocytosis Associated With 2 Cases of Pediatric Lymphocyte-depleted Classic Hodgkin Lymphoma.
Cader FZ; Colmenero I; Mussai F
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e341-e345. PubMed ID: 30601404
[TBL] [Abstract][Full Text] [Related]
14. Infection of T lymphocytes in non-Asian patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Imashuku S
Pediatr Blood Cancer; 2009 Dec; 53(7):1359; author reply 1360. PubMed ID: 19533652
[No Abstract] [Full Text] [Related]
15. A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells.
Fergusson NJ; Adeel K; Kekre N; Atkins H; Hay KA
Front Immunol; 2023; 14():1178403. PubMed ID: 37180149
[TBL] [Abstract][Full Text] [Related]
16. A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Zanetti SR; Velasco-Hernandez T; Gutierrez-Agüera F; Díaz VM; Romecín PA; Roca-Ho H; Sánchez-Martínez D; Tirado N; Baroni ML; Petazzi P; Torres-Ruiz R; Molina O; Bataller A; Fuster JL; Ballerini P; Juan M; Jeremias I; Bueno C; Menéndez P
Mol Ther; 2022 Feb; 30(2):550-563. PubMed ID: 34478871
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic Lymphohistiocytosis: Lessons Learned from the Dark Side.
Chellapandian D
Immunol Allergy Clin North Am; 2020 Aug; 40(3):485-497. PubMed ID: 32654694
[TBL] [Abstract][Full Text] [Related]
18. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
[TBL] [Abstract][Full Text] [Related]
19. CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study.
Wei G; Zhang Y; Zhao H; Wang Y; Liu Y; Liang B; Wang X; Xu H; Cui J; Wu W; Zhao K; Nagler A; Chang AH; Hu Y; Huang H
Cancer Immunol Res; 2021 Sep; 9(9):1061-1070. PubMed ID: 34290048
[TBL] [Abstract][Full Text] [Related]
20. Perinatal tuberculosis associated hemophagocytic lymphohistiocytosis.
Maheshwari P; Chhabra R; Yadav P
Indian J Pediatr; 2012 Sep; 79(9):1228-9. PubMed ID: 22246612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
